Acadia Pharma (ACAD) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $22.09 --0%
EPS Growth %: -62.5%
Financial Fact:
Net loss: -71.61M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: -62.5%
Financial Fact:
Net loss: -71.61M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q2 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $264.6 million versus the consensus estimate of $262.44 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Western Union Co. (WU) Reiterated at Market Perform by Citizens amid Retail Decline
- Keurig Dr Pepper coffee chief to depart ahead of planned split
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
